On Tuesday, seven prominent CEOs and leaders of pharmaceutical companies appeared before the Senate Finance Committee at a congressional hearing called to address the industry’s relentless raising of drug prices.
On Tuesday, seven prominent CEOs and leaders of pharmaceutical companies appeared before the Senate Finance Committee at a congressional hearing called to address the industry’s relentless raising of drug prices.